Hydrochloric Acid

Hydrochloric Acid

SCHEMBL895838

CCCCCCCCCCCCCCCCCC(C)(C)NCCC[Si](OC)(OC)OC.Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
EPHX1 P07099 2/20 0.33
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
ACAT1 P24752 1/20 0.30
SOAT1 P35610 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2747780 1.00 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
Hydrochloric Acid SCHEMBL6559392 1.00 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123152 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL2135346 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL27124590 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123281 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
Bromide SCHEMBL15564400 0.97 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
Bromide SCHEMBL16931586 0.97 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123424 0.90 LMNA (0.39) LMNA
Hydrochloric Acid SCHEMBL352060 0.89 LMNA (0.41) LMNAEPHX1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117162-A1 FOOD POISONING BACTERIA DETECTION SENSOR POSTECH Research and Business Development Foundation (KR) 2026-04-30 US claimed
EP-4673515-A1 SILICON-BASED LIQUID CRYSTAL ALIGNMENT AGENT FOR SMART WINDOWS Saint-Gobain Glass France (FR) 2026-01-07 EP claimed
US-12455470-B2 Assembly and method for actively controlling radiation transmission THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2025-10-28 US claimed
EP-4613708-A1 MOLECULAR SIEVE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2025-09-10 EP claimed
EP-4561349-A1 COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER Affix Labs Oy (FI) 2025-06-04 EP claimed
US-12290799-B2 Hierarchically ordered crystalline microporous materials with long-range mesoporous order having hexagonal symmetry SAUDI ARABIAN OIL COMPANY (SA) 2025-05-06 US claimed
EP-4516862-A1 AQUEOUS COATING COMPOSITION, COATING OBTAINED FROM THE COATING COMPOSITION, SUBSTRATE CONTAINING THE COATING AND THE USE OF THE AQUEOUS COATING COMPOSITION DAW SE (DE) 2025-03-05 EP claimed
US-20250066620-A1 WATER-BORNE HYBRID VARNISH AND THE METHOD OF ITS PREPARATION Vysoké ucení technické v Brne 2025-02-27 US claimed
EP-4495303-A1 BIOCIDAL PRODUCT WITH LUMINESCENT MARKER ADDITIVE FOR TEXTILE SURFACES OR THE LIKE Ancor Tecnológica Canaria, S.L. (ES) 2025-01-22 EP claimed
EP-4103635-B1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES SANITIZED AG (CH) 2025-01-08 EP claimed
US-20130128131-A1 LUMINESCENT SOLAR CONCENTRATOR AND METHOD FOR MAKING THE SAME, THE UNIVERSITY OF SYDNEY (AU) 2013-05-23 US claimed
US-20130068615-A1 Membrane and Sensor with Membrane TECHNISCHE UNIVERSITÄT DORTMUND (DE) 2013-03-21 US claimed
US-8178119-B2 Zinc pyrithione, triclosan, polymeric binder, fluorocarbon hydrophobicizing agent; against colonization by house dust mites; mattress ticking, furniture covering fabrics and carpets SANITIZED AG (CH) 2012-05-15 US claimed
US-20120081778-A1 PIGMENT-BASED INK HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-04-05 US claimed
WO-2011060132-A2 STETHOSCOPE DISINFECTING APPARATUS 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-05-19 WO claimed
US-20080260860-A1 Method for the Acaricidal Finishing of Textile Materials SANITIZED AG (CH) 2008-10-23 US claimed
US-20080199502-A1 Antimicrobial Solution Comprising a Metallic Salt and a Surfactant CTT GROUP INC. (CA) 2008-08-21 US claimed
US-20060110351-A1 Use of silanes on cosmetic agents and methods for treating hair ITN NANOVATION AG (DE) 2006-05-25 US claimed
US-5169561-A Altering hydrophobicity of particulate silica with a quaternary ammonium organosilane DOW CORNING CORPORATION (US) 1992-12-08 US claimed
US-5064613-A Organosilicon Quaternary Ammonium Silatrane DOW CORNING CORPORATION (US) 1991-11-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117162-A1 FOOD POISONING BACTERIA DETECTION SENSOR MLN, DSTYK, MASTL LMNA 2258/4885EPHX1 4778/4885KDM4E 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.